BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)
EUR 0.05
(0.0%)
EUR 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.92 Million | -2.81 Million | -2.52 Million | -2.41 Million | -1.44 Million | -1.7 Million |
| Net Income | -3.48 Million | -3.09 Million | -2.77 Million | -2.73 Million | -1.63 Million | 380 Thousand |
| Depreciation & Amortization | 217 Thousand | 225 Thousand | 231 Thousand | 214 Thousand | 225 Thousand | 229 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 299 Thousand | 35 Thousand | -46 Thousand | 97 Thousand | -29 Thousand | -78 Thousand |
| Other non-cash items | 45 Thousand | 17 Thousand | 66 Thousand | 2000.00 | -2000.00 | -2.23 Million |
| Investing Cash Flow | - | -78 Thousand | -125 Thousand | -82 Thousand | -24 Thousand | -34 Thousand |
| Investments in PPE | - | -78 Thousand | -125 Thousand | -82 Thousand | -24 Thousand | -34 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.37 Million | 3.17 Million | 443 Thousand | 5.42 Million | 299 Thousand | 3.38 Million |
| Debt repayment | -503 Thousand | -583 Thousand | -307 Thousand | -317 Thousand | -2000.00 | -116 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.88 Million | 3.7 Million | - | 5.73 Million | 301 Thousand | 3.5 Million |
| Other Financing Activities | 50 Thousand | 50 Thousand | 750 Thousand | 1000.00 | 298.00 | 3401.00 |
| Accounts receivables | 292 Thousand | -48 Thousand | -122 Thousand | -70 Thousand | -47 Thousand | -33 Thousand |
| Accounts payables | 7000.00 | 83 Thousand | 76 Thousand | -9000.00 | 18 Thousand | -45 Thousand |
| Inventory | -7.00 | -83.00 | -76.00 | - | -18.00 | - |
| Other working capital | 7.00 | 83.00 | 76.00 | 176 Thousand | 18.00 | -45.00 |
| Cash at beginning of period | 1.51 Million | 1.23 Million | 3.43 Million | 516 Thousand | 1.68 Million | 35 Thousand |
| Cash at end of period | 1.97 Million | 1.51 Million | 1.23 Million | 3.43 Million | 516 Thousand | 1.68 Million |
| Capital Expenditure | - | -78 Thousand | -125 Thousand | -82 Thousand | -24 Thousand | -34 Thousand |
| Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
| Net cash flow / Change in cash | 454.22 Thousand | 281 Thousand | -2.2 Million | 2.92 Million | -1.16 Million | 1.65 Million |
| Free Cash Flow | -2.92 Million | -2.89 Million | -2.64 Million | -2.5 Million | -1.46 Million | -1.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -857.00 | -857.00 | -1.84 Million | -3.48 Million | -920.81 | -1.64 Million |
| Depreciation & Amortization | 53.50 | 53.50 | 109 Thousand | 217 Thousand | 54.50 | 108 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -0.50 | -0.50 | 237 Thousand | 299 Thousand | 118.50 | 62 Thousand |
| Other non-cash items | 16.00 | 16.00 | -15 Thousand | 45 Thousand | 1.81 | 195 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 226.00 | 226.00 | 1.79 Million | 3.37 Million | 896.00 | 1.58 Million |
| Debt repayment | -452 Thousand | - | -457 Thousand | -503 Thousand | - | -46 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.24 Million | 3.88 Million | - | 1.63 Million |
| Other Financing Activities | 226.00 | 226.00 | 896.00 | 50 Thousand | 896.00 | 792.50 |
| Accounts receivables | 4.50 | 4.50 | 285 Thousand | 292 Thousand | 142.50 | 7000.00 |
| Accounts payables | -10 Thousand | - | -48 Thousand | 7000.00 | - | 55 Thousand |
| Inventory | - | - | 24.00 | -7.00 | - | -27.50 |
| Other working capital | -5.00 | -5.00 | -24.00 | 7.00 | -24.00 | 27.50 |
| Cash at beginning of period | 1.97 Million | -561.43 Thousand | 1.67 Million | 1.51 Million | 1671.00 | 1.51 Million |
| Cash at end of period | 850 Thousand | -562 Thousand | 1.97 Million | 1.97 Million | 150.00 | 1.67 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.12 Million | -562.00 | 299.8 Thousand | 454.22 Thousand | -1521.00 | 154.22 Thousand |
| Free Cash Flow | -788.00 | -788.00 | -1.49 Million | -2.92 Million | -746.00 | -1.43 Million |
4346
FRW
YOOIF
XWEL
MANORAMA
TGRO